Activation of the RON receptor tyrosine kinase attenuates transforming growth factor-β1-induced apoptotic death and promotes phenotypic changes in mouse intestinal epithelial cells

Carcinogenesis

Volumn 26, Issue 1, 2005, Pages 27-36

  Wang, Da ^a,b   Shen, Qi ^b   Xu, Xiang Ming ^b   Chen, Yi Qing ^b   Wang, Ming Hai ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; INTESTINE EPITHELIUM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; CADHERINS; CARRIER PROTEINS; CASPASE 3; CASPASES; CELL LINE; ENZYME ACTIVATION; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOPRECIPITATION; INTESTINAL MUCOSA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 13444304485     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh284     Document Type: Article

References (40)

1. de Santa Barbara,P., van den Brink,G.R. and Roberts,D.J. (2003) Development and differentiation of the intestinal epithelium. Cell Mol. Life Sci., 60, 1322-1332.
2. Renehan,A.G., Bach,S.P. and Potten,C.S. (2001) The relevance of apoptosis for cellular homeostasis and tumorigenesis in the intestine. Can. J. Gastroenterol., 15, 166-176.
3. Alison,M.R. and Sarraf,C.E. (1994) The role of growth factors in gastrointestinal cell proliferation. Cell Biol. Int., 18, 1-10.
4. Jiang,B., Zhang,J.S., Du,J., Urrutia,R. and Barnard,J. (2003) Growth inhibitory signaling by TGF-beta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus. Cell Signal., 15, 699-708.
5. Manning,A.M., Williams,A.C., Game,S.M. and Paraskeva,C. (1991) Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Oncogene, 6, 1471-1476.
6. Barnard,J.A., Beauchamp,R.D., Coffey,R.J. and Moses,H.L. (1989) Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc. Natl Acad. Sci. USA, 86, 1578-1582.
7. Hoosein,N.M., McKnight,M.K., Levine,A.E., Mulder,K.M., Childress,K.E., Brattain,D.E. and Brattain,M.G. (1989) Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp. Cell. Res., 181, 442-453.
8. Sheng,H., Shao,J., O'Mahony,C.A., Lamps,L., Albo,D., Isakson,P.C., Berger,D.H., DuBois,R.N. and Beauchamp,R.D. (1999) Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2. Oncogene, 18, 855-867.
9. Eppert,K., Scherer,S.W., Ozcelik,H. et al. (1996) MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86, 543-552.
10. Takagi,Y., Kohmura,H., Futamura,M., Kida,H., Tanemura,H., Shimokawa,K. and Saji,S. (1996) Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology, 111, 1369-1372.
11. Porter,A.C. and Vaillancourt,R.R. (1998) Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene, 17, 1343-1352.
12. Ronsin,C., Muscatelli,F., Mattei,M.G. and Breathnach,R. (1993) A novel putative receptor protein tyrosine kinase of the met family. Oncogene, 8, 1195-1202.
13. Rubin,J.S., Bottaro,D.P. and Aaronson,S.A. (1993) Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochem. Biophys. Acta, 1155, 357-364.
14. Wang,M.-H., Ronsin,C., Gesnel,M.C., Coupeym,L., Skeel,A., Leonard,E.J. and Breathnach,R. (1994) Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science, 266, 117-119.
15. Gaudino,G., Follenzi,A., Naldini,L., Collesi,C., Santoro,M., Gallo,K.A., Godowski,P.J. and Comoglio,P.M. (1994) RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13, 3524-3532.
16. Skeel,A., Yoshimura,T., Showalter,S.D., Tanaka,S., Appella,E. and Leonard,E.J. (1991) Macrophage stimulating protein: purification, partial amino acid sequence and cellular activity. J. Exp. Med., 173, 1227-1234.
17. Yoshimura,T., Yuhki,N., Wang,M.-H., Skeel. and Leonard,E.J. (1993) Cloning, sequencing and expression of human macrophage stimulating protein (MSP,MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J. Biol. Chem., 268, 15461-15468.
18. Han,S., Stuart,L.A. and Degen,S.J.F. (1991) Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry, 30, 9768-9780.
19. Li,B., Wang,M.-H., Kung,H.-F., Ronsin,C., Breathnach,R., Leonard,E.J. and Kamata,T. (1995) Macrophage stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor. Biochem. Biophys. Res. Commun., 216, 110-118.
20. Wang,M.-H., Montero-Julian,F.A. and Leonard,E.J. (1996) Requirement of PI-3 kinase for epithelial cell migration activated by human macrophage stimulating protein. Oncogene, 13, 2167-2175.
21. Wang,D., Shen,Q., Chen,Y.Q. and Wang,M.H. (2004) Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase. Oncogene, 23, 1668-1680.
22. Zhou,Y.Q., Chen,Y.Q., Fisher,J.H. and Wang,M.H. (2002) Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J. Biol. Chem., 277, 38104-38110.
23. Chen,Y.-Q., Zhou,Y.-Q., Angeloni-Andreazzoli,D., Kurtz,A.L., Qiang,X.-Z. and Wang,M.-H. (2000) Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cells lines. Exp. Cell Res., 261, 229-238.
24. Zhou,Y.-Q., He,C., Chen,Y.Q., Wang,D. and Wang,M.-H. (2003) Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing variants and their oncogenic potential. Oncogene, 22, 186-197.
25. Vidal,K., Grosjean,I., Evillard,J.P., Gespach,C. and Kaiserlian,D. (1993) Immortalization of mouse intestinal epithelial cells by the SV40-large T gene. Phenotypic and immune characterization of the MODE-K cell line. J. Immunol. Methods, 166, 63-73.
26. Montero-Julian,F.A., Dauny,I., Flavetta,S., Ronsin,C., Andre,F., Xerri,L., Wang,M.-H., Marvaldi,J., Breathnach,R. and Brailly,H. (1998) Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor. Hybridoma, 17, 541-551.
27. Oberhammer,F.A., Pavelka,M., Sharma,S., Tiefenbacher,R., Purchio,A.F., Bursch,W. and Schulte-Hermann,R. (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. Natl Acad. Sci. USA, 89, 5408-5412.
28. Elbashir,S.M., Harborth,J., Weber,K. and Tuschl,T. (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods, 26, 199-213.
29. Angeloni,D., Danitkovitch-Miagkova,A., Ivanov,S.V., Breathnach,R., Johnson,B.E., Leonard,E.J. and Lerman,M.I. (2000) Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples. Genes Chromosomes Cancer, 29, 147-156.
30. Dumont,N., Bakin,A.V. and Arteaga,C.L. (2003) Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells. J. Biol. Chem., 278, 3275-3285.
31. Lehmann,K., Janda,E., Pierreux,C.E., Rytomaa,M., Schulze,A., McMahon,M., Hill,C.S., Beug,H. and Downward,J. (2000) Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev., 14, 2610-2622.
32. Park,H.J., Kim,B.C., Kim,S.J. and Choi,K.S. (2002) Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line. Hepatology, 35, 1360-1371.
33. Kretzschmar,M., Doody,J., Timokhina,I. and Massague,J. (1999) A mechanism of repression of TGF-beta/Smad signaling by oncogenic Ras. Genes Dev., 13, 804-816.
34. Thiery,J.P. (2002) Epidielial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454.
35. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
36. Siegel,P.M. and Massague,J. (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer, 3, 807-821.
37. Boyer,B., Valles,A.M. and Edme,N. (2000) Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol. 60, 1091-1099.
38. Danilkovitch,A., Donley,S., Skeel,A. and Leonard,E.J. (2000) Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells. Mol. Cell. Biol. 20, 2218-2227.
39. Santoro,M.M., Penengo,L., Orecchia,S., Cilli,M. and Gaudino,G. (2000) The Ron oncogenic activity induced by the MEN2B-like substitution overcomes the requirement for the multifunctional docking site. Oncogene, 19, 5208-5211.
40. Bhowmick,N.A., Ghiassi,M., Bakin,A., Aakre,M., Lundquist,C.A., Engel,M.E., Arteaga,C.L. and Moses,H.L. (2001) Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell, 12, 27-36.